StockData
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. (NAUT) stock

NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 6/30
$2.36+0.26 (+12.38%)

Close on Nov 17, 2026Market cap $300.60MP/E –Yield –

Earnings

Nautilus Biotechnology's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 25, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$200.00K
EPS, Q3 FY2026
-$0.12
Latest guidance
Issued
Feb 25, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Nautilus Biotechnology's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 25, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Oct 27, 2026after the close$200.00K–-$0.12Release
Q2 FY2026ended Jun 30, 2026Jul 28, 2026during market hours$200.00K––Release
Q1 FY2026ended Mar 31, 2026Apr 28, 2026after the close–––Release
Q4 FY2025ended Dec 31, 2025Feb 26, 2026during market hours–––Release
Q3 FY2025ended Sep 30, 2025Oct 28, 2025during market hours–––Release
Q2 FY2025ended Jun 30, 2025Jul 31, 2025during market hours–––Release
Q1 FY2025ended Mar 31, 2025Apr 29, 2025during market hours––-$0.13Release
Q4 FY2024ended Dec 31, 2024Feb 27, 2025during market hours–––Release
Q3 FY2024ended Sep 30, 2024Oct 29, 2024during market hours–––Release
Q2 FY2024ended Jun 30, 2024Jul 30, 2024during market hours––-$0.14Release
Q1 FY2024ended Mar 31, 2024Apr 30, 2024during market hours––-$0.15Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Nautilus Biotechnology's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
operating expenses increaseFY2026+15% – +20%–NewFeb 25, 2026

Guidance history

Every forecast Nautilus Biotechnology put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Feb 25, 2026operating expenses increaseFY2026+15% – +20%New
Feb 28, 2024operating expenseFY2024+25%New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Nautilus Biotechnology filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Results
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?